In Vitro, Ex Vivo, and Clinical Evaluation of Anti-Aging Gel Containing EPA and CBD
June 2023
in “
Journal of cosmetic dermatology
”
Studysummary This study found that a topical cream containing CBD and EPA reduced signs of extrinsic skin aging, including wrinkle volume and skin elasticity, in clinical and laboratory settings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The research evaluated the anti-aging efficacy of a topical gel containing cannabidiol (CBD) and eicosapentaenoic acid (EPA) through in vitro, ex vivo, and clinical trials. The clinical trial involved 34 subjects aged 45-65. The gel showed potential in preventing, minimizing, and reversing the effects of accelerated aging, as evidenced by increased skin moisture, reduced ROS formation, and improved dermatitis. The gel also demonstrated anti-inflammatory action. The study concluded that the gel has significant anti-aging effects, with high patient satisfaction reported, and recommended long-term application for full benefits.